Symposia & Webinars

Benefits of controlling both blood pressure and LDL-cholesterol in terms of cardiovascular protection

 

Hypertension is the most dominant cause of death around the world, and it is connected to main preventable causes - like blood pressure, smoking, inactivity, obesity, and cholesterol:

  • One risk factor can double cardiovascular disease (CVD) risk, but many patients have multiple factors, so that their CVD risk could increase by 400-700%.
  • Despite treatment for hypertension there is a residual CVD risk.

Professor Bryan Williams’ presentation further includes CVD management indications, illustrating data from clinical trials about:

  • Patients’ mutations.
  • Lower LDL-cholesterol and lower systolic blood pressure (BP) on coronary events.
  • Men and women CVD incidence.
  • Statins and BP-lipid lowering effects.

Considering that BP cannot be lowered enough to eliminate completely the risk, Professor Williams explores the statins use - to get patient’s blood pressure and CVD risk down - analysing ESC guidelines recommendations.

This video is part of the session “Tackling cardiovascular diseases with a new generation of polypills” held virtually at ESC Congress 2020 on Monday August 31st, 2020, with chairperson Charalambos Vlachopoulos (Greece).

View also the other parts of the congress session: